Exchange: NASDAQ·Updated 01:41 PM EDT
XENE logo

XENE Xenon Pharmaceuticals Inc

$60.38
$0.22
(0.37%)
Today
Reported EarningsAug 6
Mkt Cap$5.83B
Vol135,852.00

About XENE

Xenon Pharmaceuticals, Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
53

Neutral Sentiment

How do you feel about XENE?

Advertisement|Remove ads.